Vistagen Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q2 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Vistagen Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q2 2019 to Q1 2024.
  • Vistagen Therapeutics, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $2.12M, a 18.6% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $2.12M -$485K -18.6% Mar 31, 2024 10-K 2024-06-11
Q2 2023 $2.49M -$443K -15.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.61M -$433K -14.3% Mar 31, 2023 10-Q 2023-08-10
Q4 2022 $2.72M -$424K -13.5% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $2.83M -$714K -20.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.93M -$697K -19.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $3.04M -$677K -18.2% Mar 31, 2022 10-K 2023-06-28
Q4 2021 $3.14M -$657K -17.3% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 $3.54M -$339K -8.73% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.63M -$326K -8.23% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $3.72M -$313K -7.78% Mar 31, 2021 10-K 2022-06-23
Q4 2020 $3.8M -$301K -7.35% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 $3.88M -$290K -6.95% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $3.96M -$278K -6.57% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $4.03M Mar 31, 2020 10-K 2021-06-29
Q4 2019 $4.1M Dec 31, 2019 10-Q 2020-02-13
Q3 2019 $4.17M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $4.24M Jun 30, 2019 10-Q 2019-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.